Advances in Pharmacology
Academic Press
Published on 1. January 1968
437 pages
978-0-08-058096-8 (ISBN)
Description
Advances in Pharmacology
More details
Other editions
Additional editions
Book
05/1968
Academic Press
€90.52
Article exhausted; check different version
Persons
Content
- Front Cover
- Advances in Pharmacology: Pharmacology, Behavior, and Clinical Aspects
- Copyright Page
- Contents
- Preface
- Contributors to This Volume
- Part IV: Pharmacology of lndolealkylamines
- Chapter 1. Introductory Remarks
- Chapter 2. Possible Mechanism of Action of Serotonin on Molluscan Muscle
- Chapter 3. Discussion of the Possible Mechanism of Action of Serotonin on Molluscan Muscle
- Chapter 4. Cerebral Tryptamine Receptors Functional Considerations
- Chapter 5. Discussion of Cerebral Tryptamine Receptors Functional Considerations
- Chapter 6. The Pharmacology of para-Chlorophenylalanine, a Selective Depletor of Serotonin Stores
- Chapter 7. Central Serotonin Neurons and Thermoregulation
- Chapter 8. Effects of Benzoquinolizines and Ring-Substituted Aralkylamines on Serotonin Metabolism
- Chapter 9. Discussion of the Effects of Benzoquinolizines and Ring-Substitutcd Aralkylamines on Serotonin Metabolism
- Chapter 10. Relation of 5-Hydroxytryptamine and Catecholamine Depletion to the Central Depressive Action of a Reserpine Derivative with Differential Action on Brain Monoamines
- Chapter 11. Factors Moclulating Brain Serotonin Turnover
- Chapter 12. Discussion of Factors Modulating Brain Serotonin Turnover
- Chapter 13. Serotonin in Brain Functional Considerations
- Chapter 14. Reporter's Remarks
- Part V: Clinical Aspects of lndolealkylamine Metabolism
- Chapter 15. Introductory Remarks
- Chapter 16. The Role of 5-Hydroxyindoles in the Carcinoid Syndrome
- Chapter 17. Discussion of the Role of 5-Hydroxyintloles in the Carcinoid Syndrome
- Chapter 18. Discussion of tlie Role of 5-Hydroxyindoles in the Carcinoid Syndrome
- Chapter 19. 5-Hydroxyindoles and the Thyroid
- Chapter 20. Discussion of 5-Hydroxyindoles and the Thyroid
- Chapter 21. 5-Hydroxyindoles in Phenylketonuric and Nonphenylkctonuric Mental Defectivcs
- Chapter 22. Discussion of 5-Hyrlroxyindoles in Phenylkctonuric antl Nonplienyl- kctonuric Mental Defectives
- Chapter 23. Tryptophan Hydroxylation in Phenylketonuria
- Chapter 24. Indole Metabolism in Hartnup Disease
- Chapter 25. Discussion of Indole Metabolism in Hartnup Disease
- Chapter 26. 5-Hydroxyindole Metabolism in Pregnancy
- Chapter 27. Effect of 5-Hydroxytryptamine on Maintenance of Pregnancy, Congenital Abnormalities, and the Development of Toxemia
- Chapter 28. 5-Hydroxyintloles and Migraine
- Chapter 29. Discussion of 5-Hydroxyindoles and Migraine
- Chapter 30. Plasma Serotonin Levels in Migraine
- Chapter 31.Reporter's Remarks
- Part VI: lndolealkylamines and Behavior
- Chapter 32. Introductory Remarks
- Chapter 33. Fate and Metabolism of Some Hallucinogenic Indolealkylamines
- Chapter 34. Fate and Metabolism of Some Hallucinogenic Indolealkylamines
- Chapter 35. Pharmacologic Studies on the Structure-Activity Relationship of Hydroxyindole Alkylamines
- Chapter 36. Discussion of the Pharmacologic Studies on the Structure-Activity Relationship of Indolealkylamines
- Chapter 37. Behavioral Changes and 5-Hydroxytryptamine Turnover in Animals
- Chapter 38. Discussion of Behavioral Changes and 5-Hydroxytryptamine Turnover in Animals
- Chapter 39. Insomnia and Decrease of Cerebral 5-Hydroxytryptamine after Destruction of the Raphe System in the Cat
- Chapter 40. Discussion of Insomnia and Decrease of Cerebral 5-Hydroxtryptamine After Destruction of the Raphe System in the Cat
- Chapter 41. Depressed States and Indolealkylamines
- Chapter 42. Discussion of Depressed States and Indolealkylamines
- Chapter 43. Reporter's Remarks
- Author Index
- Subject Index
